Селективная тазовая лимфаденэктомия при раке тела матки
Шаповалов Дмитрий Алексеевич, Нечушкина Валентина Михайловна, Комаров Игорь Геннадьевич et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2012
Until now pelvic and paraaortic lymph node dissection is not a standard surgical treatment for endometrial cancer even in patients at high risk of regional metastases. The purpose of this study was to develop indications for selective pelvic lymphadenectomy in endometrial cancer patients. We analyzed results of the treatment of 298 patients with stage IA-IIIC endometrial cancer aged 30 to 89 years treated at the N. N. Blokhin Russian Cancer Research Center RAMS in 1998-2004. Eighteen patients (6.0%) had regional lymph node metastases. The 5-year overall and disease-free survival was 77.8±2.5 and 73.0±2.3%. The respective 10-year rates were 69.9±2.9 and 65.8±3.6%. Risk factors for regional lymph node metastases included mixed carcinoma, deep myometrial invasion, invasion of cervical stroma, tumor size more than 4 cm and pelvic peritoneum involvement. The risk of regional metastases was 2.5 to 100% depending on the presence and combination of these risk factors.
Cited by 0 works.